Apart from interferon-γ and interferon-α responses, the IL-6/JAK/STAT3 signaling pathway suppresses the anti-tumor immune response (75), the NOD-like receptor signaling pathway affects the stages of inflammation-associated tumorigenesis (76), and the Toll-like receptor signaling pathway was a crucial access to promote invasion in OC patients (77). Here, STAT3 is linked to neoplasm.